Learning Hub

< BACK AI-Driven Early Prediction and Personalised Care | iPROLEPSIS, AI-PROGNOSIS & REBECCA Mar 3, 2026 A joint video highlighting how digital biomarkers and real-world data support patient-centred healthcare across three disease areas What happens when a disease enters someone’s life and changes everything? Millions of people live with chronic conditions that shape their daily routines – often in ways that are invisible to others. Early diagnosis, timely intervention and more effective care can make a profound difference. In a new joint video developed with support from the European Commission’s Booster initiative, the EU-funded projects iPROLEPSIS , AI-PROGNOSIS and REBECCA present a shared vision for patient-centred artificial intelligence in healthcare. The video highlights how AI and digital biomarkers can enable earlier prediction, continuous monitoring and more personalised care across three disease areas: Psoriatic arthritis (iPROLEPSIS) Parkinson’s disease (AI-PROGNOSIS) Breast cancer survivorship (REBECCA) By integrating real-world behavioural data, wearable sensor signals and patient-reported information, the projects demonstrate how complex health data can be transformed into actionable clinical insights. These AI-driven approaches aim to strengthen clinical decision-making while keeping patients at the centre of care. The video reflects the projects’ commitment to developing trustworthy, responsible and co-designed AI solutions that respond to real clinical and patient needs. Watch the video here: To learn more, visit: iPROLEPSIS – https://www.iprolepsis.eu AI-PROGNOSIS – https://www.ai-prognosis.eu REBECCA – https://www.rebeccaproject.eu Screenshot 2026-03-02 115452.png Screenshot 2026-03-02 115452.png 1/1 PREVIOUS NEXT

iPROLEPSIS project news Mar 3, 2026 AI-Driven Early Prediction and Personalised Care | iPROLEPSIS, AI-PROGNOSIS & REBECCA A joint video highlighting how digital biomarkers and real-world data support patient-centred healthcare across three disease areas READ MORE Feb 3, 2026 Co-Designing Mobile Serious Games to Support Patients With Psoriatic Arthritis and Chronic Pain: Mixed Methods Study New peer-reviewed publication from iPROLEPSIS READ MORE Dec 4, 2025 iPROLEPSIS at Faculdade de Motricidade Humana PhD Seminar Lecture on recent findings shared with PhD students READ MORE Nov 6, 2025 iPROLEPSIS at IEEE-EMBS BSN 2025 Showcasing iPROLEPSIS at a leading international conference on body sensor research READ MORE Oct 29, 2025 World Psoriasis Day: iPROLEPSIS featured by HaDEA On World Psoriasis Day, the European Health and Digital Executive Agency (HaDEA) highlights how the iPROLEPSIS project is advancing early detection and personalised care for psoriatic arthritis READ MORE Oct 8, 2025 iPROLEPSIS presented at the MULTIPULM project kick-off meeting iPROLEPSIS tools to be adapted for clinical studies in Brazil, Serbia, and Türkiye READ MORE Jul 24, 2025 iPROLEPSIS Games Pitch video from HiTech 2025 iPROLEPSIS Games presented during the HiSeedTech programme READ MORE Feb 5, 2026 Modeling Interphalangeal Joints for Swelling Assessment in Psoriatic Arthritis via Smartphone Photographs New iPROLEPSIS publication presents a smartphone-based approach for remote joint swelling assessment in psoriatic arthritis READ MORE Dec 23, 2025 Seasons Greetings from iPROLEPSIS Happy holidays and best wishes for the year ahead! READ MORE Nov 25, 2025 iPROLEPSIS Showcased at MEDICA 2025 Project presented by PLUX at an international medical technology trade fair READ MORE Nov 6, 2025 iPROLEPSIS Newsletter No. 10 Latest News from iPROLEPSIS READ MORE Oct 29, 2025 World Psoriasis Day 2025: Advancing Prevention and Care On World Psoriasis Day, iPROLEPSIS highlights ongoing efforts to improve early detection, prevention, and digital support for people living with psoriasis and psoriatic arthritis READ MORE Oct 2, 2025 iPROLEPSIS at the European Researchers’ Night 2025 Presentation of the iPROLEPSIS Games in Oeiras, Portugal by FMH/IST-ULisboa researchers READ MORE Jul 18, 2025 iPROLEPSIS at GRAPPA 2025: Advancing Digital Tools for Psoriatic Arthritis Care Exploring how digital biomarkers can support hand function assessment in real-world settings READ MORE Feb 4, 2026 Designing Exergames for Psoriatic Arthritis: The Spy and Zen Forest Paradigms New iPROLEPSIS publication presents the co-design of exergames to support physical activity and rehabilitation in psoriatic arthritis READ MORE Dec 12, 2025 iPROLEPSIS 7th Plenary Meeting in Lisbon Partners met to review progress and next steps READ MORE Nov 24, 2025 iPROLEPSIS Games Showcased at Lisboa Games Week 2025 The FMH/IST-ULisboa team presented the iPROLEPSIS Games, connecting with the gaming community and industry stakeholders READ MORE Nov 3, 2025 iPROLEPSIS at IEEE HealthCom 2025: AI-Enabled Digital Health for Psoriatic Arthritis Project researchers presented new studies, co-chaired a workshop, and joined a panel on digital innovation in healthcare in Abu Dhabi READ MORE Oct 14, 2025 The iPROLEPSIS Learning Hub Has Been Renewed A refreshed space to learn more about psoriatic arthritis READ MORE Sep 11, 2025 Digital Innovation for Psoriatic Arthritis Prevention An interview with iPROLEPSIS coordinators in Thessalonikeon Polis on how digital tools, wearables, and AI can help prevent psoriatic arthritis READ MORE 1 2 3 ... 6 1 ... 1 2 3 4 5 6 ... 6

The iPROLEPSIS project is where psoriatic arthritis inflammation is explained through multi-source data analysis guiding a novel personalized digital care ecosystem. iPROLEPSIS is a s olution for psoriatic arthritis The iPROLEPSIS project is where psoriatic arthritis inflammation is explained through multi-source data analysis guiding a novel personalised digital care ecosystem. ABOUT CONSORTIUM CONTACT US March 2026 TODAY Mon Tue Wed Thu Fri Sat Sun 23 24 25 26 27 28 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 1 2 3 4 5 Upcoming events Psoriatic Arthritis (PsA) is a chronic progressive inflammatory disease affecting 1-2% of the general population, while manifesting in up to 30% of people with psoriasis (PsO). Project vision and impact iPROLEPSIS is a Horizon Europe-funded project developing a novel personalised digital care ecosystem for people with PsA. The goal of iPROLEPSIS is to propose a novel ecosystem that involves Real World Data (RWD) collection mechanisms and a powerful decision support system to provide new knowledge for the key actionable factors that affect the health-to-PsA transition, adopting a multiscale/ multifactorial approach, so, with the use of xAI-based models, to offer an efficient, effective, and clinically validated personalised digital care ecosystem for PsA patients. DISCOVER MORE Project objectives and work packages iPROLEPSIS consortium works on 7 ambitious key objectives in the field of Psoriatic Arthritis (PsA) and has 6 Work Packages of the project that will bring together various and complementary expertise from consortium partners. DISCOVER MORE About project 15 Partners 9 Countries 48 m Project duration € 6,4M Total budget The core activity domains Establishment • The foundation for the project’s research activities is laid by means of an extensive exploration of the available literature and data and the design of the clinical data collection and validation studies; • Participatory design supporting the development of a user-oriented ecosystem of solutions will be employed to establish a framework for trustworthy AI-based R&D. Validation • The design and implementation of the clinical studies that will collect research data, validate the inflammatory symptoms digital biomarkers in individuals at risk of PsA and PSO patients, and evaluate the efficacy of the digital care tools with respect to prevention of inflammation exacerbation. Research and development • Research on multimodal data to reveal key PsA inflammation drivers, provide digital biomarkers of PsA inflammatory symptoms, and explore the effect of PsA on the joints and skin microvasculature, as well as the role of mast cells in PsA transition; • Synthesise the outcomes into a multiscale/multifactorial model of the health-to-PsA transition; • Deliver the integrated iPROLEPSIS digital health ecosystem comprising tools for personalised preventive PsA care, to empower patients and HCPs. Learning Hub Explore resources to help you understand and manage psoriatic arthritis. Handbook Handbook 2 Psoriatic Arthritis Key Facts Key Facts Psoriatic Arthritis Handbook Handbook Quizzes about Psoriatic Arthritis Take a Quiz Project news Handbook Handbook 2 AI-Driven Early Prediction and Personalised Care | iPROLEPSIS, AI-PROGNOSIS & REBECCA Read More Modeling Interphalangeal Joints for Swelling Assessment in Psoriatic Arthritis via Smartphone Photographs Read More Designing Exergames for Psoriatic Arthritis: The Spy and Zen Forest Paradigms Read More DISCOVER MORE Contact us We welcome your comments or questions about iPROLEPSIS project! CONTACT US

< BACK Highlights from IEEE MELECON 2024 Jun 28, 2024 Highlights from IEEE MELECON 2024 The iPROLEPSIS breathing games have been presented and well received by the audience at the IEEE MELECON 2024 scientific conference. The conference was held in Porto, Portugal on 25-27 June, 2024. IEEE MELECON 2024 is a major international forum presenting design methodologies, techniques, and experimental results in emerging electro-technologies. It is one of the flagship conferences of the IEEE Region 8 (the largest region of IEEE including Europe, Africa, and Middle East). It is expected to bring together researchers and practitioners from different fields of Electrical Engineering. Read more: IEEE MELECON 2024 – IEEE MELECON 2024 ( ieee-melecon.org ) . 1/5 PREVIOUS NEXT

Learning Hub Explore resources to help you understand and manage psoriatic arthritis. Learning hub Key Facts Handbook News Feed Quizzes Search How is psoriatic arthritis treated? Self-care and lifestyle See related Handbook section PREVIOUS NEXT

< BACK Innovating Psoriatic Arthritis Care with iPROLEPSIS Oct 29, 2024 Insights Shared in Psoriasis Magazine: An Interview with Psoriasis Patienten Nederland We are pleased to share that we were interviewed by Psoriasis Patients Netherlands ( https://psoriasispatientennederland.nl/ ) and featured in their Psoriasis Magazine . This dedicated volunteer organisation advocates for over 300,000 people in the Netherlands affected by psoriasis and psoriatic arthritis. Supporting Patients Psoriasis Patients Netherlands provides clear, unbiased information on managing chronic conditions and serves as a vital link between patients, healthcare providers, and the latest research. Their focus is on patient support, offering resources like their magazine, social media, and direct support channels, creating an invaluable network for those navigating these challenging conditions. Digital Health Innovation The Erasmus MC in Rotterdam, through the iPROLEPSIS Consortium , is developing an app to help patients with psoriatic arthritis monitor their condition using digital health tools. Over 600 patients across four countries will use the app and smartwatches to track their heart rate, activity, and symptoms daily, along with periodic video analyses and healthcare visits. Key Research Areas The key research areas include exploring the roles of genetics, gut microbiome, and lifestyle factors. Collaborations with organizations like HPOS will soon allow individuals with psoriasis to contribute their data, supporting predictive models for earlier diagnosis. Empowering Patients Through Partnership The Erasmus MC’s iPROLEPSIS study is not just about technological development; it is driven by the stories of patient partners like Elaine and Wendy. Their lived experience with psoriatic arthritis informs our work, ensuring that the tools we develop support their needs and enhance their well-being. With patient partners at the core of the iPROLEPSIS initiative, we are creating a future where digital tools empower psoriatic arthritis patients. 1/1 PREVIOUS NEXT

Learning Hub Explore resources to help you understand and manage psoriatic arthritis. Learning hub Key Facts Handbook News Feed Quizzes Search What is psoriatic arthritis? See related Handbook section PREVIOUS NEXT

< BACK ChatGPT in Nutrition: Trends, Challenges and Future Directions Jun 27, 2024 Exploring the Role of AI in Shaping the Future of Personalised Nutrition Introducing our latest iPROLEPSIS publication, "ChatGPT in Nutrition: Trends, Challenges, and Future Directions" , presented at PETRA 2024. This study explores the evolving role of AI in personalized nutrition. Abstract: A healthy and balanced diet is of paramount importance to the physical and psychological well-being of an individual, since unhealthy dietary choices have been linked with the occurrence of non-communicable diseases. Recent technological advances has led to the development of large language models, such as ChatGPT that has been widely adopted as a convenient tool for creating meal plans and obtaining nutritional information. This work aims to provide a thorough review of the scientific work performed so far regarding the use of ChatGPT in the field of nutrition. In this survey, the advantages and limitations of ChatGPT in different aspects of nutrition are pinpointed, while the challenges from the use of ChatGPT in nutrition are identified and discussed. Future research directions are also proposed to assist researchers towards the development of more effective nutrition recommendation systems. Read the full publication: https://zenodo.org/records/13142880 ChatGPT in Nutrition .pdf Download PDF • 620KB 1/1 PREVIOUS NEXT

Learning Hub Explore resources to help you understand and manage psoriatic arthritis. Learning hub Key Facts Handbook News Feed Quizzes Search How will psoriatic arthritis affect me? Emotional wellbeing See related Handbook section PREVIOUS NEXT

< BACK iPROLEPSIS joins the YouTube channel Jan 23, 2024 Join Our Digital Journey – Follow iPROLEPSIS on YouTube iPROLEPSIS has officially joined the YouTube community . Follow our YouTube Channel: iPROLEPSIS - YouTube . Join us as we delve into novel digital solutions for psoriatic arthritis. Stay tuned for informative and engaging content! transparent-glass-bubble-with-youtube-logo-inside-it.jpg transparent-glass-bubble-with-youtube-logo-inside-it.jpg 1/1 PREVIOUS NEXT

< BACK iPROLEPSIS Games Presented at the Pitch Competition during PhD Open Days Nov 7, 2024 Showcasing iPROLEPSIS Games at the PhD Open Days Pitch Competition On November 5th, Bárbara Ramalho from FMH/IST-ULisboa had the opportunity to present the iPROLEPSIS Games at the Pitch Competition during the PhD Open Days event at the Técnico Innovation Center . In her pitch, Bárbara highlighted the role of serious games in the iPROLEPSIS project, which aims to improve the care and management of psoriatic arthritis (PsA) through a personalised, game-based digital ecosystem. The PhD Open Days gave over a thousand students the chance to connect, network, and showcase their research to the academic community, industry professionals, and alumni. The Pitch Competition was a great opportunity for researchers to present their work and meet potential collaborators. 1/5 PREVIOUS NEXT

< BACK iPROLEPSIS presented to Eli Lilly in the Netherlands Nov 8, 2023 Presentation to Eli Lilly introduces iPROLEPSIS as the next step in personalised psoriatic arthritis care On the 7th of November 2023, Ilja Tchetverikov from CICERO Rheumatology presented the results and prospects of the DEPAR cohort and introduced iPROLEPSIS clinical studies to the representatives of Eli Lilly company in the Netherlands. DEPAR, Dutch south-west Psoriatic Arthritis Registry, is a registry set up by Cicero Rheumatology, a partnership of rheumatologists working in 15 different hospitals in the south-west of the Netherlands. DEPAR, with the participation of well over 900 patients, supports rheumatologists to gain insight into the treatment and course of psoriatic arthritis. The presentation highlighted iPROLEPSIS as a logical next step in the further development of DEPAR, emphasising the project’s vision and aim to explain psoriatic arthritis inflammation through multi-source data analysis, guiding to a novel personalised digital care ecosystem. Slide1.JPG Slide2.JPG Slide6.JPG Slide1.JPG 1/6 PREVIOUS NEXT